Headache (R) Flashcards

1
Q

International Headache Society (IHS) classification

A

-migraine
-tension-type headache
-cluster headache

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

tx goals for migraine

A

-rapid & consistent tx
-restore functional ability
-use lowest, effective dose of abortive therapy
-minimize adverse events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

non-pharmacological interventions: migraines

A

maintain headache diary to identify potential triggers & practice avoidance
-use of ice, rest, bio-feedback

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

urgent medical eval for “red flags”

A

-new-onset sudden +/- severe pain
-stereotyped pain pattern worsens
-systemic signs (fever, wt loss, accelerated HTN)
-focal neurologic sxs (other than typical visual/sensory aura)
-papillederma
-cough-, exertion-, or Valsalva-triggered headache
-pregnancy or postpartum state
-pts w/ cancer, HIV & other infectious & immunodeficient disorders
-seizures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

if n/v present in migraine headache treat

A

antiemetic: consider IV, IM, SQ, or nasal formulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

mild-moderate migraine sxs …Rx

A

-simple, analgesics NSAIDs

-APAP alone is not recommended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

severe migraine sxs or if no relief from NSAIDs for mild-moderate sxs .. Rx

A

combo analgesics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

first-line tx choice for mild to moderate attacks or severe attacks that have responded in the past to similar tx

A

oral NSAIDs

&

combination analgesics w/ caffeine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

butalbital-containing products

A

drug class: barbiturates

-limit & monitor use due to overdose
-medication-overuse headache
-withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

acetaminophen (APAP): dosing & max

A

1000mg at onset
repeat q4-6h as needed
max=4g/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

APAP + ASA +caffeine

A

APAP 250mg + ASA 250mg + caffeine 65mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ASA or APAP, caffeine

A

1-2 tablets q4-6h

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

isometheptene + dichloraphenazone + acetaminophen

A

isometheptene 65mg + dichloraphenazone100mg+ acetaminophen 325mg 2 capsules at onset, repeat 1 capsule every hour as needed

max 6 capsules in 24hr

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ASA

A

500-1000 mg q 4-6hr; max 4g/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ibuprofen: dose & max

A

200-800 mg q6h; avoid >2.4 g/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

naproxen sodium

A

550-825 mg at onset; may repeat 220mg in 3-4h

avoid > 1.375g/day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

first-line therapy for moderate to severe migraines especially when nonspecific (OTC (Excedrin migraine)) are ineffective

A

triptans

if no response to one, try another

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

triptans contraindications

A

-hx of ischemic heart disease
-uncontrolled HTN
-CAD
-stroke
-PVD
-Prinzmetal’s angina
-MI
-pregnancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

moderate to severe migraine attacks when other tx failures

A

ergotamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ergotamines: CIs

A

-pts w/at risk for CAD
-stroke
-PVD
-uncontrolled HTN
-liver/kidney disease
-strong inhibitors of CYP3A5
-pregnancy (cat X)

21
Q

opioids

A

moderate to severe infrequent headaches

“last resort” due to contraindications or failed response to conventional therapies

22
Q

lasmiditan

A

a selective serotonin 1F receptor agonist that lacks vasoconstrictor activity

for contraindications to triptans due to cardiovascular risk factors

23
Q

s/e of lasmiditan

A

decrease HR and/or increase BP
-dizziness, paresthesia, somnolence, fatigue, N

duration 1.5-2h

no driving, operating machinery, engage in hazardous activities for at least 8h after EACH dose

24
Q

lasmiditan: life threatening

A

serotonin syndrome

w/ [SSRIs, SNRI, triptans, TCA, fentanyl, lithium, tramadol, buspirone, St. John’s wort, tryptophan) or w/o other drug associates

-impair serotonin metabolism: MAOIs
-other contributing: MAOIs: linezolid and IV methylene blue

25
serotonin syndrome: s/s
-mental status changes [agitation, hallucination, delirium, coma] -autonomic instability [tachycardia, labile BP, diaphoresis] -neuromuscular changes [tremor, rigidity, myoclonus] -GI sxs [N/V/D] -seizures discontinue tx
26
CGRP antagonists
pharmacological modulation of calcitonin-gene related peptide (CGRP) activity appears to mediate trigeminovascular pain transmission in migraines
27
CGRP available for
"gepants" for acute tx of migraine in patients w/ either insufficient response or contraindication (CAD) to tx w/ triptans
28
ubrogepant & rimegepants
acute migraine tx for adults
29
adjuvant therapy to relieve N/V & migraine attack
***chlorpromazine, prochlorprezamine*** -IV formulation for refractory, intractable headache -administer 15-30m before abortive therapy ***metoclopramide*** IV (a DA receptor blocker) effective for acute migraine tx
30
prophylactic therapy considerations
-quality of life, business duties, or school attendance are severely impaired -frequency of attacks are equal/greater than 2/month -migraine attacks do not respond to acute drug tx -frequent, very long, or uncomfortable auras occur
31
beta-blockers
propranolol ideal for health pts/comorbid HTN, angina, or anxiety ***avoid in reactive airway disease, heart block, bradycardia***
32
TCAs
**nortriptyline, amitryptiline** comorbid depression/insomnia ***avoid: urinary retention, BPH, glaucoma, anticholinergic effects are problematic***
33
anticonvulsants
**valproate, topirimate** for comorbid seizure disorder/manic-depressive illness (many drug interactions)
34
CCBs
**verapamil** generally considered 2nd or 3rd line for migraine headaches ***first for prophylaxis of cluster type of headache***
35
NSAIDs
use for migraines w/ predictable pattern (eg. menstrual cycle) -initiate 1-2d prior to expected onset of headache -total duration of use limited due to risk of GI events
36
triptans
use for migraines w/ predictable patter (eg. menstrual cycle) -for pts that are unresponsive to NSAIDs, not considered standard of practice
37
botox
15 or more headaches a month, each lasting 4h or more
38
CGRP antagonist
little evidence of use
39
MOH abbr
medication overuse headache headache occurring on 15 or more days per month developing as a consequence of regular overuse of acute/symptomatic headache medication for more than 3 months
40
highest risk for MOH
-opioids -butalbital-containing analgesics -acetaminophen-aspirin caffeine combos
41
prevention of MOH
limit most meds to less than 10 days per month or less than 15d for ASA, APAP, NSAIDs
42
cluster headache
severe headache on one side of the head w/ recurrent on fixed time intervals
43
cluster headache s/s
-swollen/drooping eye -smaller pupil in the eye -eye redness/watering -running/congested nose -red/warm face -sweating
44
cluster headache causes
-smoking -alcohol -disruptions in your circadian rhythm (sleep deprivation, jet lag)
45
cluster headache tx
-measure to abort the acute episode w/ meds such as **sumatriptan** -o2 (dec severity) -avoid alcohol
46
cluster headache: acute tx
-submatriptan subq inj -zolmitripan nasal spray -sumatriptan nasal spry -o2 -nVNV (for ECH)
47
cluster headache: interim tx
-oral prednisolone -greater occipital nerve block
48
cluster headache: preventative
-verapamil -topiramate -lithium -melatonin -nVNS -SPG microstimulator